Living Nanoparticle^™

The world’s first cellular delivery platform technology for in vivo genetic medicines

Cellular
Bioreactor

In vivo gene editing and mRNA delivery

Immuno-Vaccinology

Genetically engineered cellular bioreactors produce living nanoparticles that deliver in vivo mRNA as infectious or cancer vaccines with the goal of improving efficacy, safety, and durability compared to existing vaccine technologies.

Genetically engineered cellular bioreactors produce living nanoparticles that deliver in vivo mRNA as infectious or cancer vaccines with the goal of improving efficacy, safety, and durability compared to existing vaccine technologies.